Altun G.D.Serim B.D.Özdemir E.Özdemir S.Şen F.Demir H.Tosun F.C.2024-06-122024-06-1220202149-6447https://doi.org/10.4274/NTS.GALENOS.2020.0014https://hdl.handle.net/20.500.14551/16802Sympathetic innervation of the heart plays an important role in the pathophysiology of diseases, especially congestive heart failure and arrhythmias. Iodine-123 metaiodobenzylguanidine (I-123 MIBG) scintigraphy allows for early detection of problems by imaging at the neurotransmitter level before cardiac structural changes occur. In this way, it is possible to correctly manage the diagnosis and treatment processes of the patients. The main purpose of this guide is to ensure the national standardization of cardiac I-123 MIBG scintigraphy applications. In addition, it is intended to guide nuclear medicine doctors in the proper execution of indications, imaging and clinical processes, evaluation and reporting stages. © Telif Hakkı 2020 Türkiye Nükleer Tıp Derneği / Nükleer Tıp Seminerleri, Galenos Yayınevi tarafından yayınlanmıştır.tr10.4274/NTS.GALENOS.2020.0014info:eu-repo/semantics/openAccess1-123 Mibg; Cardiac Sympathetic Innervation; Scintigraphy(3 Iodobenzyl)Guanidine I 123; Article; Cardiac Imaging; Clinical Assessment; Clinical Evaluation; Heart Innervation; Heart Scintiscanning; Human; Nuclear Medicine; Practice Guideline; Standardization; Treatment IndicationArticle621982102-s2.0-85183292728N/A